Sign inJoin waitlistJoin the waitlist

Edward Snyder

Dean & William S. Beinecke Professor of Economics and Management · Yale-New Haven Hospital

Credentials: · · · · · · ·

History

Transfusion Medicine Scientific Program Committee
2008–Present
Economics and Management · Yale-New Haven Hospital
Present
DSMC · Yale Cancer Center
Present

Hematology
1978–1979
Blood Banking and Transfusion Medicine
1977–1978
Montefiore Hospital and Medical Center
1975–1977
Montefiore Hospital and Medical Center
1976–1977
Montefiore Hospital
1973–1975
New York Medical College
1969–1973

Research

Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling
Proceedings of the National Academy of Sciences of the United States of America · 2010 · 424 citations
Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations
Biology of Blood and Marrow Transplantation · 2014 · 328 citations
Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial
Blood · 2004 · 324 citations

RS
Ronald Strauss
14 papers
Donald Buchholz
12 papers
RB
Richard Benjamin
12 papers
Christopher Tormey
11 papers · 5 as a fellow
Henry Rinder
10 papers · 3 as a fellow
LC
Laurence Corash
10 papers
Dennis Cooper
8 papers
Eric Gehrie
8 papers · 1 as a resident
JM
John Mccullough
6 papers
Yanyun Wu
6 papers
AB
Arthur Bracey
5 papers
Diane Krause
5 papers

Grants

Recipient Epidemiology and Donor Evaluation Study III (REDS-III) - Domestic Site - Phase 3
National Heart, Lung, and Blood Institute · N01
Contact PI · $8.2M · Yale University
2011–2017
Stem Cell Transplantation in 2020: A Workforce and Infrastructure Assessment
National Heart, Lung, and Blood Institute · R13
Contact PI · $10K · National Marrow Donor Program
2011–2012
Chronic DTH and IFN-Gamma in Human Graft Arteriosclerosis
National Heart, Lung, and Blood Institute · P01
Project lead · $668.6K · Yale University
2006–2011
Symposium on Emerging Cardiac Cellular Therapies
National Heart, Lung, and Blood Institute · R13
Contact PI · $10K · Yale University
2005–2006

Clinical trials

A Open Label, Post Marketing Surveillance Study Following Transfusion of INTERCEPT Platelet Components
Principal investigator · Completed
Cerus Corporation
2015–2021